Tag:
L-dopa
Latest Headlines
Latest Headlines
Civitas' inhaled L-dopa Parkinson's treatment passes Phase I
Civitas Therapeutics generated positive top line results in a Phase I trial of CVT-301, its inhaled version of L-dopa to treat Parkinson's disease-related tremors. The drug, which is ingested through
